Single-Dose Nimodipine Normalizes Impaired Retinal Circulation in Normal Tension Glaucoma

Journal of Glaucoma

Volumn 13, Issue 2, 2004, Pages 158-162

  Michalk, Fabian ^a   Michelson, Georg ^a   Harazny, Joanna ^a   Werner, Ulrike ^a   Daniel, Werner G ^a   Werner, Dierk ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Clinic of Neurology   (Germany)

Author keywords

Calcium channel blocker; Nimodipine; Normal tension glaucoma; Retinal perfusion

Indexed keywords

NIMODIPINE; NIMOTOP S;

ADULT; ARTICLE; CAPILLARY FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; LOW TENSION GLAUCOMA; MALE; PRIORITY JOURNAL; RETINA BLOOD FLOW; SINGLE DRUG DOSE; VASOSPASM;

BLOOD CIRCULATION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NIMODIPINE; OPTIC DISK; REGIONAL BLOOD FLOW; RETINAL DISEASES; RETINAL VESSELS; VASODILATION;

EID: 1642341455     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200404000-00013     Document Type: Article

References (20)

1. Cioffi GA. Three assumptions: Ocular blood flow and glaucoma. J Glaucoma. 1998;7:299-300.
2. 2+-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989;227: 408-412.
3. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma. 1998;7:336-342.
4. Bose S, Piltz JR, Breton ME. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology. 1995; 102:1236-1241.
5. Chung HS, Harris A, Evans DW, et al. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999; 43(Suppl 1):43-50.
6. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998;7:372-377.
7. Tomita G, Niwa Y, Shinohara H, et al. Changes in optic nerve head blood flow and retrobulbar hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmology. 1999;23: 3-10.
8. Yamamoto T, Kitazawa Y. Vascular pathogenesis of normal tension glaucoma: a possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy. Prog Retin Eye Res. 1998;17:127-143.
9. Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann N Y Acad Sci. 1988;522:698-706.
10. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001; 20:319-349.
11. Gengo FM, Fagan SC, Krol G, et al. Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls. Br J Clin Pharmacol. 1987;23:47-53.
12. Raemsch KD, Ahr G, Tettenborn D, et al. Overview on pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgia (Stuttg). 1985;28:74-78.
13. Michelson G, Schmauss B. Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol. 1995;79:1126-1132.
14. Michelson G, Schmauss B, Langhans MJ, et al. Principle, validity and reliability of scanning laser Doppler flowmetry. J Glaucoma. 1996;5:99-105.
15. Michelson G, Welzenbach J, Pal I, et al. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol. 1998;82:1294-1300.
16. Michelson G, Groh M, Langhans M, et al. 2-dimensional mapping and retinal and papillary microcirculation using scanning laser Doppler flowmetry. Klin Monatsbl Augenheilkd. 1995;207:180-190.
17. Tsujikawa A, Kiryu J, Nonaka A, et al. Reproducibility of scanning laser Doppler flowmetry in the rat retina and optic nervehead. Jpn J Ophthalmol. 2000;44:257-262.
18. Chauhan BC, Smith FM. Confocal scanning laser Doppler flowmetry: experiments in a model flow system. J Glaucoma. 1997;6:237-245.
19. Hill G, Forbes W, Kozak J, et al. Likelihood and clinical trials. J Clin Epidemiol. 2000;53:223-227.
20. Hunter AJ. Calcium antagonists: their role in neuroprotection. Int Rev Neurobiol. 1997;40:95-108.